Viyash Scientific Schedules Q4 FY26 Earnings Conference Call for May 20, 2026
Viyash Scientific Limited has scheduled a conference call for May 20, 2026, at 4:00 PM IST to discuss its Q4 FY26 financial results. Key management, including the MD & Group CEO and CFO, will participate.
This is a forward-looking announcement about a conference call to discuss results, not the results themselves. The immediate impact on the stock is likely to be minimal.
The announcement is a routine scheduling of a conference call to discuss financial results, which is a standard corporate practice and does not inherently indicate positive or negative performance.
Viyash Scientific Limited (formerly known as Sequent Scientific Limited) has announced that it will hold a conference call with analysts and investors on Wednesday, May 20, 2026, at 4:00 PM Indian Standard Time. The call is scheduled to discuss the company's financial results for the fourth quarter of the fiscal year 2026 (Q4 FY26).
The conference call will feature presentations from key management personnel, including Dr. Hari Babu Bodepudi, Managing Director & Group CEO; Mr. Rajaram Narayanan, Executive Director and CEO – Animal Health; and Mr. Ramakant Singani, Chief Financial Officer.
Details for joining the call include universal access dial-in numbers: +91 22 6280 1263 and +91 22 7115 8213. Information regarding early registration via a Diamond Pass is also available. The details of this conference call are also accessible on the company's website, www.viyash.com, in the Investors Section.
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.